110 related articles for article (PubMed ID: 25663115)
1. Evolving-pattern analysis of transient and long-term biomarkers for cancers: Hepatocellular carcinoma as a case.
Wang Y; Cai Y; Miao Y
Interdiscip Sci; 2015 Feb; ():. PubMed ID: 25663115
[TBL] [Abstract][Full Text] [Related]
2. Evolving-Pattern Analysis of Transient and Long-Term Biomarkers for Cancers: Hepatocellular Carcinoma as a Case.
Wang Y; Cai Y; Miao Y
Interdiscip Sci; 2015 Dec; 7(4):414-22. PubMed ID: 26264055
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
4. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.
Zhao Q; Zhang Y; Shao S; Sun Y; Lin Z
PeerJ; 2021; 9():e10594. PubMed ID: 33552715
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
7. Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma.
Wei L; Lian B; Zhang Y; Li W; Gu J; He X; Xie L
BMC Genomics; 2014; 15 Suppl 1(Suppl 1):S13. PubMed ID: 24564407
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma.
Wang W; Deng Z; Jin Z; Wu G; Wang J; Zhu H; Xu B; Wen Z; Guo Y
Medicine (Baltimore); 2022 Jan; 101(4):e28694. PubMed ID: 35089224
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma.
Tu J; Chen J; He M; Tong H; Liu H; Zhou B; Liao Y; Wang Z
Onco Targets Ther; 2019; 12():5153-5162. PubMed ID: 31303768
[TBL] [Abstract][Full Text] [Related]
10. Identification of Biomarkers Associated with Hepatocellular Carcinoma Stem Cell Characteristics Based on Co-Expression Network Analysis of Transcriptome Data and Stemness Index.
Zhao Z; Mu H; Feng S; Liu Y; Zou J; Zhu Y
Crit Rev Eukaryot Gene Expr; 2022; 32(2):47-60. PubMed ID: 35381131
[TBL] [Abstract][Full Text] [Related]
11. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
[TBL] [Abstract][Full Text] [Related]
13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
14. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
Cai C; Wang W; Tu Z
J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
[No Abstract] [Full Text] [Related]
15. Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma.
Li YR; Zong RQ; Zhang HY; Meng XY; Wu FX
Front Genet; 2022; 13():861096. PubMed ID: 35350239
[No Abstract] [Full Text] [Related]
16. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
17. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
18. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.
De Giorgi V; Monaco A; Worchech A; Tornesello M; Izzo F; Buonaguro L; Marincola FM; Wang E; Buonaguro FM
J Transl Med; 2009 Oct; 7():85. PubMed ID: 19821982
[TBL] [Abstract][Full Text] [Related]
19. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
